Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway

被引:95
作者
Ivanova, AV [1 ]
Ivanov, SV
Danilkovitch-Miagkova, A
Lerman, MI
机构
[1] NCI, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
[2] NCI, Intamural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr,Lab Immunobiol, Ft Detrick, MD 21702 USA
关键词
D O I
10.1074/jbc.M010516200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we focus on different modes of regulation of STRA13, a human ortholog of the mouse basic helix-loop-helix transcriptional factor, previously identified by us as a new von Hippel-Lindau tumor suppressor gene (VHL) target. The gene was overexpressed in VHL-deficient cell lines and tumors, specifically clear cell renal carcinomas and hemangioblastomas, Introduction of wild type VHL transgene into clear cell renal carcinoma restored low level expression of STRA13, Overexpression was also detected in many common malignancies with an intact VHL gene, suggesting the existence of another, VHL-independent pathway of STRA13 regulation, Similar to many other von Hippel-Lindau tumor-suppressor protein (pVHL) targets, the expression of STRA13 on the mRNA level was hypoxia-sensitive, indicating oxygen-dependent regulation of the gene, presumably through the pVHL/hypoxia-inducible factor 1 (HIF-1) pathway. The yeast two-hybrid screening revealed interaction of the STRA13 protein with the human ubiquitin-conjugating enzyme (UBC9) protein, the specificity of which was confirmed in mammalian cells. By adding the proteasome inhibitor acetyl-leucinyl-leucinyl-norleucinal, we demonstrated that the 26 S proteasome pathway regulates the stability of pSTRA13, Go-expression of STRA13 and UBC9 led to an increase of the pSTRA13 ubiquitination and subsequent degradation. These data established that UBC9/STRA13 association in cells is of physiological importance, presenting direct proof of UBC9 involvement in the ubiquitin-dependent degradation of pSTRA13, Hypoxia treatment of mammalian cells transiently expressing STRA13 protein showed that stability of pSTRA13 is not affected by hypoxia or VHL, Thus, STRA13, a new pVHL target, is regulated in cells on multiple levels. We propose that STRA13 may play a critical role in carcinogenesis, since it is a potent transcriptional regulator, abundant in a variety of common tumors.
引用
收藏
页码:15306 / 15315
页数:10
相关论文
共 55 条
[31]  
Köhler M, 1999, EXP NEPHROL, V7, P290
[32]   Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes [J].
Kovalenko, OV ;
Plug, AW ;
Haaf, T ;
Gonda, DK ;
Ashley, T ;
Ward, DC ;
Radding, CM ;
Golub, EI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2958-2963
[33]   von Hippel-Lindau protein induces hypoxia-regulated arrest of tyrosine hydroxylase transcript elongation in pheochromocytoma cells [J].
Kroll, SL ;
Paulding, WR ;
Schnell, PO ;
Barton, MC ;
Conaway, JW ;
Conaway, RC ;
Czyzyk-Krzeska, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30109-30114
[34]   Regulation of p53 stability by Mdm2 [J].
Kubbutat, MHG ;
Jones, SN ;
Vousden, KH .
NATURE, 1997, 387 (6630) :299-303
[35]  
LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P649
[36]   The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins:: Function and regulation [J].
Lüscher, B ;
Larsson, LG .
ONCOGENE, 1999, 18 (19) :2955-2966
[37]   A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2 [J].
Mahajan, R ;
Delphin, C ;
Guan, TL ;
Gerace, L ;
Melchior, F .
CELL, 1997, 88 (01) :97-107
[38]   Poly(ADP-ribose) polymerase interacts with a novel human ubiquitin conjugating enzyme: hUbc9 [J].
Masson, M ;
MenissierdeMurcia, J ;
Mattei, MG ;
deMurcia, G ;
Niedergang, CP .
GENE, 1997, 190 (02) :287-296
[39]   A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex [J].
Matunis, MJ ;
Coutavas, E ;
Blobel, G .
JOURNAL OF CELL BIOLOGY, 1996, 135 (06) :1457-1470
[40]   SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex [J].
Matunis, MJ ;
Wu, JA ;
Blobel, G .
JOURNAL OF CELL BIOLOGY, 1998, 140 (03) :499-509